1. Pink Sheet

US FDA and ARPA-H: Woodcock Has Questions

 
• By Derrick Gingery

The FDA’s principal deputy commissioner wonders how the agency will work with ARPA-H to help get its projects to patients and the health care system given its other responsibilities.

Health care innovation
Woodcock says FDA will have to work closely with the Advanced Research Project Agency for Health not long after projects advance beyond the discovery stages. • Source: Shutterstock

Janet Woodcock still has questions about how President Biden’s health care discovery accelerator ARPA-H and the FDA will work together to bring new ideas to the health care system and patients.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from R&D

More from Pink Sheet